06.08.2026
FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledge
The FDA released draft guidance aimed at helping developers bring promising gene therapies to patients more efficiently by leveraging existing scientific and regulatory knowledge throughout the development process. The draft guidance, once finalized, will provide recommendations for sponsors developing human gene therapy products that use genome editing in human somatic cells.